Cowen Downgrades Myriad Genetics (MYGN) to Market Perform
Cowen downgraded Myriad Genetics (NASDAQ: MYGN) from Outperform to Market ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
